About Greg Brozeit
Articles by Greg Brozeit
Myeloma Round Tables: Something for EveryoneMar 14, 2023
A Love of Humanity Focused on Cancer: Dr. Parameswaran HariMar 07, 2023
Expanding Clinical Trials: Norway’s Gift to Myeloma?Feb 07, 2023
Three-to-Five Years: It’s Not a Looming Sentence AnymoreSep 09, 2022
Myeloma Survivorship: The News Is Better Than We ThoughtSep 02, 2022
Myeloma Round Table: Studies from the American Society of Hematology Meeting (ASH 2021), January 22, 2022Jul 20, 2022
Myeloma Crowd Round Table in Berlin, Germany on June 4May 07, 2022
Antibody Study Highlights Heidelberg Myeloma AgendaFeb 21, 2022
Myeloma Numbers: More and Less Than They SeemNov 04, 2021
IMW: Hartmut Goldschmidt’s Tenacity Benefits Myeloma Patients EverywhereOct 05, 2021
IMW: A Czech Pioneer in MyelomaSep 30, 2021
MCRT Webcast: ASCO/EHA Meeting Review (Part 1)Jul 23, 2021
MCRT Webcast: BCMA and Other TargetsMay 22, 2021
COVID Vaccination Guidelines for Myeloma Patients ReleasedFeb 07, 2021
MCRT Webcast: Side Effects of Myeloma TreatmentJan 29, 2021
MCRT Webcast: High-Risk Disease EssentialsJan 16, 2021
MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed MyelomaJan 08, 2021
MCRT Webcast: The Promise of CAR T Cell TherapyDec 23, 2020
MCRT Webcast: Understanding Myeloma Stem Cell TransplantationDec 18, 2020
MCRT Webcast: Making Sense of Myeloma Bone IssuesDec 05, 2020
Dr. Ola Landgren Sets Up a New Myeloma Shop in MiamiNov 25, 2020
MCRT Webcast: MGUS and Smoldering Myeloma (SMM)Nov 03, 2020
MCRT Webcast: Myeloma ImagingOct 11, 2020
MCRT Webcast: Minimal Residual Disease (MRD) Essentials: How Should Patients Interpret Results?Oct 03, 2020